Search Results 1261-1270 of 20104 for Hepatitis C

  1. Publications - Michelle C. Nguyen, M.D. - Mayo Clinic

    2025; 5(3):37. Punukollu R, Arias S, Ohara S, Nica A, Briggs LG, Cosentino C, Frasco P, Andrews P, Nguyen M, Mao S, Heimbach J, Jadlowiec C. Incisional ...

  2. Combination Therapy of Acalabrutinib, Venetoclax and Durvalumab to Treat Richter Transformation - Mayo Clinic

    Hepatitis B or C serologic status: Hepatitis B surface antigen and hepatitis B PCR positive will be excluded; Hepatitis B core antibody (anti-HBc) positive ...

  3. A Study to Evaluate Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) - Mayo Clinic

    Known to be positive for hepatitis C infection (positive by polymerase chain reaction [PCR] or on antiviral therapy for hepatitis C within the last 6 months).

  4. Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma - Mayo Clinic

    ... hepatitis C virus (detectable anti-hepatitis C circulating viral RNA); Has had a deep venous thrombosis (DVT) or pulmonary embolism within the 3 months prior ...

  5. Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1 - Mayo Clinic

    bleeding diatheses, or renal transplant, including any patient known to have hepatitis. B, hepatitis C, or human immunodeficiency virus (HIV) will be excluded.

  6. Hepatobiliary Cancer SPORE Quarterly Newsletter - Mayo Clinic

    doi: 10.1097/HEP. ... doi: 10.1097/HEP.0000000000001093. Epub ahead of ... Pereyra D, Mandorfer M, Santol J, Gregory L, Koeditz C, Ortmayr G, Schuetz C, Rumpf B,.

  7. News - Tufia C. Haddad, M.D. - Mayo Clinic

    Tufia C. Haddad, M.D.. Oncologist. Request an Appointment · Overview · News · Publications. News. Print. 2025. Mayo Clinic leads 4 decades of advances in breast ...

  8. Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

    ... hepatitis C (e.g., hepatitis C virus [HCV] ribonucleic acid RNA [qualitative] is detected); Received a live vaccine within 30 days of planned start of study ...

  9. ALSENLITE: Senolytics for Alzheimer's Disease - Mayo Clinic

    Known active hepatitis B or C infection 20. Invasive fungal or viral infection (as per clinical judgment) 21. Known hypersensitivity or allergy to D or Q 22 ...

  10. A Study to Evaluate the Safety and Effectiveness of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma Patients - Mayo Clinic

    - Has a known history of hepatitis B (defined as hepatitis B surface antigen reactive) or known active hepatitis C virus (defined as hepatitis C virus ...